We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

51 hedge funds and large institutions have $9.56M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

2% more funds holding

Funds holding: 50 → 51 (+1)

26% less capital invested

Capital invested by funds: $12.8M → $9.56M (-$3.28M)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

60% less call options, than puts

Call options by funds: $395K | Put options by funds: $984K

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
11
Closed
7
Calls
$395K
Puts
$984K
Net Calls
-$589K
Net Calls Change
+$345K

Top Buyers

1
UCFA
United Capital Financial Advisors
Texas
+$271K
2
GCP
GSA Capital Partners
United Kingdom
+$166K
3
Citadel Advisors
Citadel Advisors
Florida
+$72.8K
4
Renaissance Technologies
Renaissance Technologies
New York
+$69.1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$54K

Top Sellers

1
OM
Opaleye Management
Massachusetts
-$1.18M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$390K
3
Deutsche Bank
Deutsche Bank
Germany
-$299K
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$216K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$167K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.53M +$31.4K +25 +1%
BIT
2
BlackRock Institutional Trust
California
$1.18M -$56.5K -45 -4%
B
3
Bailard
California
$1M – – –
KCM
4
Knoll Capital Management
Florida
$562K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$418K – – –
UCFA
6
United Capital Financial Advisors
Texas
$259K +$271K +216 New
GBA
7
Garrison Bradford & Associates
New York
$247K -$2.51K -2 -0.9%
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$216K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$213K -$390K -311 -61%
SIP
10
Stoneridge Investment Partners
Pennsylvania
$213K – – –
BFA
11
BlackRock Fund Advisors
California
$206K +$30.1K +24 +15%
LCM
12
Leisure Capital Management
California
$187K – – –
Bank of New York Mellon
13
Bank of New York Mellon
New York
$164K +$2.51K +2 +1%
Northern Trust
14
Northern Trust
Illinois
$156K – – –
ARTA
15
A.R.T. Advisors
New York
$155K -$166K -132 -48%
GCP
16
GSA Capital Partners
United Kingdom
$144K +$166K +132 New
PNC Financial Services Group
17
PNC Financial Services Group
Pennsylvania
$141K -$216K -172 -57%
CCB
18
Cutter & Co Brokerage
Missouri
$130K – – –
Neuberger Berman Group
19
Neuberger Berman Group
New York
$127K – – –
BIC
20
Beach Investment Counsel
Pennsylvania
$119K -$26.4K -21 -16%
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$112K – – –
Citadel Advisors
22
Citadel Advisors
Florida
$96K +$72.8K +58 +193%
HighTower Advisors
23
HighTower Advisors
Illinois
$80K – – –
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$75K – – –
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$73K – – –
1
2 3

NBSE Hedge Fund Activity: Q2 2016 in Review

51 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q2 2016, worth a combined $9.56M — down 26% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NBSE positions and 7 closed out — a net gain of 2 holders — while 7 added to existing stakes and 11 trimmed.

The largest buyer was United Capital Financial Advisors, opening a new position worth an estimated $271K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.18M sold.

  • 51 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q2 2016, up from 50 in Q1 2016.
  • Funds reported $9.56M of NeuBase Therapeutics, Inc. Common Stock stock for Q2 2016, down 26% quarter-over-quarter.
  • 9 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q2 2016 and 7 closed out, a net change of +2 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q2 2016 was United Capital Financial Advisors, an estimated $271K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q2 2016 was Opaleye Management, an estimated $1.18M sold.

Based on aggregated 13F filings for Q2 2016.